2M6:ETR
Medtronic PLC
€77.22
arrow_downward
-0.64%(-0.50) 1D
Sep 28, 5:35:37 PM GMT+2 · EUR
search
All symbols
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2M6...
Open
€77.20
High
€78.24
Low
€77.20
Mkt. cap
114.48B
Avg. vol.
1.49K
Volume
1.95K
52-wk high
€91.50
52-wk low
€62.86
No. of employees
95K
Open
€77.20
High
€78.24
Low
€77.20
Mkt. cap
114.48B
Avg. vol.
1.49K
Volume
1.95K
52-wk high
€91.50
52-wk low
€62.86
No. of employees
95K
News stories
From web sources and news partners
Stock Titan
·
7 hours ago
[425] Medtronic plc Business Combination Communication
MarketBeat
·
10 hours ago
Promising Medical Stocks To Keep An Eye On - September 28th
AD HOC NEWS
·
11 hours ago
Medtronic stock at USD 88.29 on September 28, 2026
HME News
·
13 hours ago
MiniMed names new general counsel to help scale company
Profile
Medtronic plc is an American company originally United States founded by American Earl Bakken like Johnson Controls and trane technologie two American company based in Ireland medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue.
The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote patient monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
About Medtronic PLC
Last report
Sep 1, 2026
Fiscal period
Q1 2027
EPS / Est. (USD)
$1.45 / $1.39
+4.51%beat
arrow_upward
Revenue / Est. (USD)
9.76B / 9.54B
+2.21%beat
arrow_upward
Fiscal Q1 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
Revenue | 8.96B | 9.02B | 9.81B | 9.76B |
Cost of goods sold | 3.06B | 3.17B | 3.40B | 3.41B |
Cost of revenue | 3.06B | 3.17B | 3.40B | 3.41B |
Research and development expenses | 754.00M | 722.00M | 671.00M | 771.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 2.94B | 2.93B | 3.04B | 3.17B |
Operating expense | 4.08B | 4.04B | 4.25B | 4.46B |
Total operating expenses | 7.14B | 7.21B | 7.64B | 7.87B |
Operating income | 1.82B | 1.80B | 2.16B | 1.89B |
Other non operating income | 3.00M | 13.00M | 154.00M | 33.00M |
EBT including unusual items | 1.60B | 1.40B | 1.84B | 1.77B |
EBT excluding unusual items | 1.68B | 1.66B | 2.16B | 1.82B |
Income tax expense | 215.00M | 254.00M | 575.00M | 289.00M |
Effective tax rate | 13.47% | 18.10% | 31.34% | 16.35% |
Other operating expenses | -29.00M | -79.00M | 126.00M | 113.00M |
Net income | 1.37B | 1.14B | 1.24B | 1.47B |
Net profit margin | 15.33% | 12.68% | 12.68% | 15.07% |
Earnings per share | 1.36 | 1.36 | 1.55 | 1.45 |
Interest and investment income | 89.00M | 102.00M | 73.00M | 102.00M |
Interest expense | -181.00M | -181.00M | -176.00M | -186.00M |
Net interest expenses | -92.00M | -79.00M | -103.00M | -84.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 2.52B | 2.52B | 2.88B | 2.62B |
Gain or loss from assets sale | - | - | - | - |